The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pathology and Oncology Research

• Publication date

  2012-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12253-012-9539-3PMID 22544356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

  2010cited by this paper
• High-mobility group box 1 and cancer.

  2010cited by this paper
• HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer

  2010cited by this paper
• Suppression of Dendritic Cells by HMGB1 Is Associated with Lymph Node Metastasis of Human Colon Cancer

  2009cited by this paper
• Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers

  2009cited by this paper
• Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

  2009cited by this paper
• Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.

  2009cited by this paper
• Effect of Small Interference RNA Targeting HIF-1α Mediated by rAAV Combined l-Ascorbate on Pancreatic Tumors in Athymic Mice

  2009cited by this paper
• Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature.

  2009cited by this paper
• Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

  2009cited by this paper
• Cytolytic cells induce HMGB1 release from melanoma cell lines

  2007cited by this paper
• Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

  2005cited by this paper
• Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death

  2005cited by this paper
• Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

  2004cited by this paper
• Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy

  2003cited by this paper
• Demonstration of the Rat Lymphatic Vessels Using Immuohistochemistry and In Situ Hybridization for 5'-Nucleotidase

  2003cited by this paper
• Dual roles for HMGB1: DNA binding and cytokine

  2001cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper

• The role of HMGB1 in digestive cancer.

  2023cites this paper
• HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC

  2022cites this paper
• Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma

  2022cites this paper
• HMGB1 knockdown increases the radiosensitivity of esophageal squamous cell carcinoma by regulating the expression of molecules involved in DNA repair

  2021cites this paper
• Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression

  2021cites this paper
• Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma

  2021cites this paper
• HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner

  2020cites this paper
• Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Impact of perioperative high mobility group box chromosomal protein 1 expression on long‐term outcomes in patients with esophageal squamous cell carcinoma

  2020cites this paper
• Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1

  2019cites this paper
• Cytoplasmic HMGB1 and HMGB1-Beclin1 complex are increased in radioresistant oral squamous cell carcinoma.

  2019cites this paper
• Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

  2019cites this paper
• High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy

  2019cites this paper
• Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype

  2019cites this paper
• Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer

  2019cites this paper
• High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater

  2019cites this paper
• High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas.

  2018cites this paper
• HMGB 1 expression in urothelial carcinoma of the bladder

  2018cites this paper
• Increased expression of high mobility group box protein 1 and vascular endothelial growth factor in placenta previa.

  2017cites this paper
• Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.

  2016cites this paper
• Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells

  2016cites this paper
• The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review

  2016cites this paper
• HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review

  2016cites this paper
• Alarmins and Antitumor Immunity.

  2016cites this paper
• Increased expression of HMGB 3 : a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma

  2015cites this paper
• Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.

  2015cites this paper
• HMGB1 overexpression correlates with poor prognosis in early-stage squamous cervical cancer

  2015cites this paper
• Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer.

  2015cites this paper
• High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.

  2015cites this paper
• Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression

  2015cites this paper
• Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

  2015cites this paper
• Effect of ulinastatin on the expression and distribution of high mobility group box 1 in human colon carcinoma cells in vitro.

  2015cites this paper
• The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

  2015cites this paper
• High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma

  2015cites this paper
• The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer

  2014cites this paper
• Does HMGB1 predict occult neck lymph node metastasis in early tongue carcinoma? A case–control study of 26 patients

  2014cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• Clinical Significance of HMGB1 Expression in Human Gastric Cancer

  2014cites this paper
• HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target

  2014cites this paper
• Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis

  2013cites this paper
• Ultraviolet light exposure stimulates HMGB1 release by keratinocytes

  2013cites this paper
• Low expression of cyclic amp response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma

  2013cites this paper
• The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer

  2013cites this paper